Skip to main content
Veterinary Medicines

WELLICOX 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES

Authorised
  • Flunixin meglumine

Product identification

Medicine name:
WELLICOX 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES
Wellicox 50 mg/ml injektionsvæske, opløsning
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
  • Pig
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        31
        day
      • Milk
        36
        hour
    • Pig
      • Meat and offal
        20
        day
    • Horse
      • Meat and offal
        10
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        24
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Vetem S.p.A.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 50207
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0241/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 3/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."